Amgen Stock in Trouble, Despite Strong Results
Amgen Inc. (NASDAQ:AMGN) reported its full year 2017 results on February 1st. On a non-GAAP basis, the California-based biotech giant earned $12.58 per share,...
All from AMGN STOCK
Amgen Stock in Trouble, Despite Strong Results
Amgen Inc. (NASDAQ:AMGN) reported its full year 2017 results on February 1st. On a non-GAAP basis, the California-based biotech...
